Related Experiment Video
Updated: Sep 3, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
[Initial management of immune thrombocytopenia]
Julien Derême1, Marine Gossin1, Amandine Segot1,2
1Service et laboratoire central d'hématologie, Département d'oncologie et Département de médecine de laboratoire et pathologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
Immune thrombocytopenia (ITP) is one of the most common causes of thrombocytopenia. The diagnosis is established when platelet counts are consistently below 100 × 109/L, after excluding alternative etiologies through a targeted laboratory workup. However, the initial evaluation should always be adapted to the clinical context, taking rare causes into consideration. Establishing an accurate diagnosis is essential, as it allows for the prompt initiation of appropriate treatment tailored to the individual situation and facilitates long-term management. In this article, the diagnostic workup and the initial therapeutic management of ITP are discussed.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
